The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23
Yıl: 2022 Cilt: 14 Sayı: 2 Sayfa Aralığı: 239 - 243 Metin Dili: İngilizce DOI: 10.4274/jcrpe.galenos.2021.2020.0269 İndeks Tarihi: 05-07-2022
The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23
Öz: Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disorder. Topical sodium thiosulfate (STS) and
acetazolamide can be a safe and effective treatment for patients who do not respond to conventional therapy for ectopic calcifications.
We report the successful treatment of deep soft-tissue calcifications with topical STS and acetazolamide in a boy diagnosed with HFTC
due to a novel homozygous mutation of FGF23.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Olgu Sunumu Erişim Türü: Erişime Açık
- 1. Benet-Pagès A, Orlik P, Strom TM, Lorenz-Depiereux B. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 2005;14;385-390. Epub 2004 Dec 8
- 2. Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M, Khamaysi Z, Behar D, Petronius D, Friedman V, Zelikovic I, Raimer S, Metzker A, Richard G, Sprecher E. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 2004;36;579-581. Epub 2004 May 9
- 3. Ichikawa S, Imel EA, Kreiter ML, Yu X, Mackenzie DS, Sorenson AH, Goetz R, Mohammadi M, White KE, Econs MJ. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Musculoskelet Neuronal Interact 2007;7:318-319.
- 4. Finer G, Price HE, Shore RM, White KE, Langman CB. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms. Am J Med Genet A 2014;164;1545-1549. Epub 2014 Mar 25
- 5. Ramnitz MS, Gourh P, Goldbach-Mansky R, Wodajo F, Ichikawa S, Econs MJ, White KE, Molinolo A, Chen MY, Heller T, Del Rivero J, Seo-Mayer P, Arabshahi B, Jackson MB, Hatab S, McCarthy E, Guthrie LC, Brillante BA, Gafni RI, Collins MT. Phenotypic and Genotypic Characterization and Treatment of a Cohort With Familial Tumoral Calcinosis/Hyperostosis-Hyperphosphatemia Syndrome. J Bone Miner Res 2016;31;1845-1854. Epub 2016 Sep 20
- 6. Jost J, Bahans C, Courbebaisse M, Tran TA, Linglart A, Benistan K, Lienhardt A, Mutar H, Pfender E, Ratsimbazafy V, Guigonis V. Topical Sodium Thiosulfate: A Treatment for Calcifications in Hyperphosphatemic Familial Tumoral Calcinosis? J Clin Endocrinol Metab 2016;101;2810-2815. Epub 2016 May 10
- 7. Tiwari V, Zahra F. Hyperphosphatemic Tumoral Calcinosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan. 2022 Feb 28. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK572152/
- 8. Christov M, Jüppner H. Phosphate homeostasis disorders. Best Pract Res Clin Endocrinol Metab 2018;32;685-706. Epub 2018 Jun 18
- 9. Garringer HJ, Malekpour M, Esteghamat F, Mortazavi SM, Davis SI, Farrow EG, Yu X, Arking DE, Dietz HC, White KE. Molecular genetic and biochemical analyses of FGF23 mutations in familial tumoral calcinosis. Am J Physiol Endocrinol Metab 2008;295;929-937. Epub 2008 Aug 5
- 10. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17;405-424. Epub 2015 Mar 5
- 11. Folsom LJ, Imel EA. Hyperphosphatemic familial tumoral calcinosis: genetic models of deficient FGF23 action. Curr Osteoporos Rep 2015;13;78-87.
- 12. Claramunt-Taberner D, Bertholet-Thomas A, Carlier MC, Dijoud F, Chotel F, Silve C, Bacchetta J. Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia? Pediatr Nephrol 2018;33;1263-1267. Epub 2018 Mar 28
- 13. Burja S, Jovic A, Ekart R, Piko N, Miljkovic J, Breznik V. Successful treatment of extensive uremic calciphylaxis with intravenous sodium thiosulfate and its potential in treating various diseases of pathologic calcification. Acta Dermatovenerol Alp Pannonica Adriat 2019;28;37- 40.
| APA | Doneray H, OZDEN A, GÜRBÜZ K (2022). The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. , 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| Chicago | Doneray Hakan,OZDEN AYSE,GÜRBÜZ KADRİ The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. (2022): 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| MLA | Doneray Hakan,OZDEN AYSE,GÜRBÜZ KADRİ The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. , 2022, ss.239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| AMA | Doneray H,OZDEN A,GÜRBÜZ K The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. . 2022; 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| Vancouver | Doneray H,OZDEN A,GÜRBÜZ K The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. . 2022; 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| IEEE | Doneray H,OZDEN A,GÜRBÜZ K "The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23." , ss.239 - 243, 2022. 10.4274/jcrpe.galenos.2021.2020.0269 |
| ISNAD | Doneray, Hakan vd. "The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23". (2022), 239-243. https://doi.org/10.4274/jcrpe.galenos.2021.2020.0269 |
| APA | Doneray H, OZDEN A, GÜRBÜZ K (2022). The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. Journal of Clinical Research in Pediatric Endocrinology, 14(2), 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| Chicago | Doneray Hakan,OZDEN AYSE,GÜRBÜZ KADRİ The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. Journal of Clinical Research in Pediatric Endocrinology 14, no.2 (2022): 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| MLA | Doneray Hakan,OZDEN AYSE,GÜRBÜZ KADRİ The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. Journal of Clinical Research in Pediatric Endocrinology, vol.14, no.2, 2022, ss.239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| AMA | Doneray H,OZDEN A,GÜRBÜZ K The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. Journal of Clinical Research in Pediatric Endocrinology. 2022; 14(2): 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| Vancouver | Doneray H,OZDEN A,GÜRBÜZ K The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23. Journal of Clinical Research in Pediatric Endocrinology. 2022; 14(2): 239 - 243. 10.4274/jcrpe.galenos.2021.2020.0269 |
| IEEE | Doneray H,OZDEN A,GÜRBÜZ K "The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23." Journal of Clinical Research in Pediatric Endocrinology, 14, ss.239 - 243, 2022. 10.4274/jcrpe.galenos.2021.2020.0269 |
| ISNAD | Doneray, Hakan vd. "The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in FGF23". Journal of Clinical Research in Pediatric Endocrinology 14/2 (2022), 239-243. https://doi.org/10.4274/jcrpe.galenos.2021.2020.0269 |
